Globus Medical, Inc. GMED
NYSE
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -3.28% | 3.92% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.28% | 3.92% | |||
| Cost of Revenue | -3.53% | 3.15% | |||
| Gross Profit | -3.17% | 4.26% | |||
| SG&A Expenses | -0.68% | -3.70% | |||
| Depreciation & Amortization | 0.05% | 0.12% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.06% | -0.63% | |||
| Operating Income | -6.97% | 20.71% | |||
| Income Before Tax | -3.45% | 20.85% | |||
| Income Tax Expenses | 10.06% | 16.71% | |||
| Earnings from Continuing Operations | -6.86% | 21.94% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.86% | 21.94% | |||
| EBIT | -6.97% | 20.71% | |||
| EBITDA | -4.91% | 14.31% | |||
| EPS Basic | -6.24% | 22.21% | |||
| Normalized Basic EPS | -6.92% | 21.39% | |||
| EPS Diluted | -5.45% | 22.22% | |||
| Normalized Diluted EPS | -6.61% | 21.81% | |||
| Average Basic Shares Outstanding | -0.67% | -0.23% | |||
| Average Diluted Shares Outstanding | -1.00% | -0.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||